Patent Expiry
TLX: ILLUCCIX: recorded patent 11027031 expiry
July 28, 2035 · GALLIUM GA-68 GOZETOTIDE. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- July 28, 2035
- Company
- Telix Pharmaceuticals Limited (TLX)
- Drug
- GALLIUM GA-68 GOZETOTIDE
BioSniper AIPage context preserved
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Patent Expiry
ILLUCCIX: recorded patent 11027031 expiry
Orange Book application NDA214032, product 001, listed patent 11027031 expiry. Overall loss of exclusivity and current company rights: unknown.FDA source
- Drug
- GALLIUM GA-68 GOZETOTIDE